ALFA FinderNSE filing, NSE: RISHABH. Summary written from the filing by ALFA Finder's alert engine.
Rishabh Instruments Ltd: key numbers
- Share price
- ₹632.10
- Market cap
- ₹2,454 Cr
- Revenue (annual)
- ₹775.1 Cr
- Net profit (annual)
- ₹81.53 Cr
- P/E (TTM)
- 30.4×Sector 44.3×
- Promoter holding
- 69.28%-0.12% QoQ
- FII holding
- 2.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rishabh Instruments Ltd
All →Rishabh Instruments Q2 FY27 Results: Net Profit ₹18.1 Cr, Down 18.1% YoY
Rishabh Instruments Ltd reported revenue from operations of ₹212.8 Cr (+8.4% YoY) and net profit of ₹18.1 Cr (-18.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹18.1 Cr · -18.1% YoY
Rishabh Instruments Board Meeting Date
Rishabh Instruments will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. This is an advance notice, so the outcome is not yet known.
Rishabh Instruments Employee Stock Options
Rishabh Instruments Limited allotted 1,22,295 equity shares under its Employee Stock Option Plan 2022 - Scheme A to eligible employees, pursuant to exercise of options.
Rishabh Instruments Other Announcement
The company filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Rishabh Instruments Employee Stock Options
Rishabh Instruments Limited granted 1,00,000 employee stock options at an exercise price of Rs. 250 per share. The grant follows the company's existing ESOP Plan 2022.
Rishabh Instruments Other Announcement
KMP and employee disclosed market sales of equity shares under PIT regulations.
Other other announcement announcements
All →Park Medi World Other Announcement
Park Medi World filed Crisil's monitoring agency report on IPO proceeds for quarter ended September 30, 2026. Utilisation deviated from prospectus objects, reallocated under shareholder approval.
AKG Exim Other Announcement
AKG Exim filed its consolidated related party transactions disclosure for the half year ended September 30, 2026. It lists routine dealings with directors, KMP and related entities.
Prodocs Solutions Other Announcement
Prodocs Solutions submitted its IPO proceeds monitoring report for the quarter ended September 30, 2026. No deviation from issue objects was reported, so it is routine compliance.
CPS Shapers Other Announcement
CPS Shapers filed auditor certificates on preferential issue proceeds utilised until 30 September 2026. The filing reports utilisation only, with no new capital raised.
GE Power India Other Announcement
GE Power India updated contact details of KMPs authorised for materiality determination and disclosures. This is routine compliance paperwork with no financial or business event.
KRM Ayurveda Other Announcement
KRM Ayurveda submitted CARE Ratings' monitoring agency report for the quarter ended September 30, 2026 on IPO proceeds utilisation. The report shows no deviation from the offer objects.